Interim stay on order suspending manufacture of 14 Patanjali drugs: Official

An interim stay has been placed on the implementation of an order suspending manufacturing licenses for over a dozen medicines produced by Patanjali Ayurved Ltd and Divya Pharmacy. The stay follows a preliminary inquiry report from a high-level committee, stating that the suspension order was illegal and should not have been issued in the manner it was. The firms challenged the suspension order issued last month by the Uttarakhand state licensing authority, citing a lack of adherence to established legal procedures.